Benefits
Stress and Anxiety Reduction
KSM-66 lowers cortisol levels, helping to alleviate stress and anxiety. Clinical studies show it promotes a calmer state of mind under mental pressure.
Cognitive Enhancement
KSM-66 supports memory and cognitive function by enhancing neurotransmitter activity. It may improve focus and mental clarity, especially in stressful conditions.
Improved Sleep Quality
KSM-66 promotes better sleep by calming the nervous system. Users often report falling asleep faster and experiencing deeper rest.
Enhanced Physical Performance
KSM-66 boosts endurance and strength by improving energy metabolism. It supports muscle recovery and exercise performance in athletes.
Testosterone and Fertility Support
KSM-66 increases testosterone levels and improves male fertility by enhancing sperm quality. Clinical trials demonstrate its role in supporting reproductive health.
Immune System Support
KSM-66 strengthens immune function through its adaptogenic properties. It helps the body resist infections and maintain overall vitality.
Mechanism of action
Stress and Anxiety Reduction
KSM-66 reduces cortisol production by modulating the hypothalamic-pituitary-adrenal (HPA) axis, calming the stress response. Its withanolides also enhance GABA receptor activity, promoting relaxation and reducing anxiety.
Cognitive Enhancement
KSM-66 increases acetylcholine levels and supports neuronal signaling by inhibiting acetylcholinesterase, enhancing memory and focus. It also reduces oxidative stress in the brain, protecting neurons and supporting synaptic plasticity.
Improved Sleep Quality
KSM-66 promotes GABAergic activity, calming neural excitability to facilitate faster sleep onset and deeper rest. Its stress-reducing effects further support sleep by lowering cortisol-driven arousal.
Enhanced Physical Performance
KSM-66 improves mitochondrial energy production and oxygen utilization, boosting endurance and strength. It also reduces exercise-induced muscle damage by lowering oxidative stress and inflammation.
Testosterone and Fertility Support
KSM-66 upregulates steroidogenic enzymes and balances reproductive hormones, increasing testosterone and sperm quality. Its antioxidant properties protect testicular cells, enhancing male fertility.
Immune System Support
KSM-66 enhances immune function by increasing natural killer cell activity and cytokine production. Its adaptogenic effects reduce stress-related immune suppression, bolstering overall resilience.
Clinical trials
Prospective, randomized, double-blind, placebo-controlled study of KSM-66 ashwagandha root extract (300 mg twice daily, 600 mg/day) vs placebo in 64 chronically stressed adults for 60 days. Outcomes: Perceived Stress Scale (PSS), DASS-21, serum cortisol, safety. (Indian J Psychol Med)
64 chronically stressed adults. 60-day intervention.
KSM-66® significantly reduced PSS scores (44% reduction vs placebo), DASS-21 anxiety/depression/stress subscales, and serum cortisol (~28% reduction vs placebo). Generally well-tolerated. CRITICAL CONTEXT: this is the foundational stress trial heavily cited in ashwagandha marketing. Industry-funded (Ixoreal Biomed). Independent replication has been broadly supportive but with smaller effect sizes.
Randomized, double-blind, placebo-controlled trial of KSM-66 ashwagandha (600 mg/day) vs placebo in 50 healthy adults with mild memory complaints for 8 weeks. Outcomes: cognitive performance battery (CANTAB-equivalent), memory scores. (J Diet Suppl)
50 healthy adults with subjective memory concerns. 8-week intervention.
KSM-66 significantly improved working memory, attention, executive function, and information processing speed vs placebo. Cognitive effects emerged at 4 and 8 weeks. Industry-funded; effect sizes reasonable. Adds to evidence for ashwagandha's cognitive applications.
Evidence review and pooled analysis examining ashwagandha (multiple branded extracts including KSM-66, Shoden) effects on sleep quality. (PLoS One)
Pooled across multiple ashwagandha sleep clinical trials.
Ashwagandha extracts (including KSM-66) significantly improved sleep quality measures (PSQI), sleep latency, and total sleep time vs placebo. Effects most pronounced in adults with insomnia or sleep disturbances. Effect sizes modest to moderate. Provides reasonable evidence for sleep applications, with multiple consistent trials.
Randomized, double-blind, placebo-controlled trial of KSM-66 (600 mg/day) vs placebo in 50 healthy athletic adults for 8 weeks. Outcomes: VO2max, recovery markers, cardiorespiratory fitness. (Ayu)
50 healthy athletic adults. 8-week intervention.
KSM-66 increased VO2max ~13.6% vs placebo and improved recovery markers. Industry-funded. Note: VO2max improvements of this magnitude with a botanical supplement are substantial — would warrant rigorous independent replication. Most ashwagandha 'performance' marketing rests on this and similar small industry-funded trials.
Randomized, double-blind, placebo-controlled trial of KSM-66 (600 mg/day, sometimes 5 g of root) vs placebo in 75 oligospermic infertile men for 12 weeks. Outcomes: sperm count, sperm motility, sperm morphology, serum testosterone, LH, FSH. (Evid Based Complement Alternat Med)
75 oligospermic infertile men. 12-week intervention.
KSM-66 significantly increased sperm count (167% improvement), sperm motility (57% improvement), and serum testosterone (17% increase) vs placebo. Industry-funded. Note: effect sizes large; specific to oligospermic infertile population — extrapolation to general male testosterone enhancement is less supported.
Randomized, double-blind, placebo-controlled trial of KSM-66 ashwagandha (600 mg/day) vs placebo in 50 women with self-reported low sexual function for 8 weeks. Outcomes: Female Sexual Function Index (FSFI), sexual satisfaction. (Biomed Res Int — or, Health Sci Rep)
50 women with low sexual function. 8-week intervention.
KSM-66 significantly improved FSFI total score, arousal, lubrication, orgasm, and sexual satisfaction vs placebo. Industry-funded. Effects attributed to stress reduction and HPA axis modulation rather than direct hormonal effects. Adds to KSM-66's broader stress/hormonal applications.
Comprehensive safety assessment of KSM-66 standardized ashwagandha root extract through battery of genotoxicity, acute and subchronic toxicity tests, plus human tolerability study. (Cureus or related Ixoreal safety publications)
Battery of toxicology + human tolerability.
KSM-66 showed no significant adverse effects on hematological, liver, kidney, or thyroid markers in human tolerability assessment. Generally well-tolerated. CONTRADICTORY EVIDENCE: separate case reports have linked ashwagandha (multiple extracts, not specifically KSM-66) to acute hepatotoxicity (report; LiverTox database lists ashwagandha as established cause of drug-induced liver injury). The discrepancy suggests rare idiosyncratic hepatotoxicity may occur despite generally good tolerance — discontinue with any hepatic warning signs.